Valuation: QuidelOrtho Corporation

Market Cap 1.03B 884M 829M 757M 1.43B 98.39B 1.44B 9.77B 3.81B 49.64B 3.88B 3.79B 164B P/E 2026 *
-3.66x
P/E 2027 * -5.43x
Enterprise Value 3.74B 3.21B 3.01B 2.75B 5.18B 357B 5.23B 35.47B 13.81B 180B 14.06B 13.75B 596B EV / Sales 2026 *
1.47x
EV / Sales 2027 * 1.41x
Free-Float
99.11%
Yield 2026 *
-
Yield 2027 * -
1 day+3.86%
1 week+12.06%
Current month-10.26%
1 month-6.23%
3 months+26.90%
6 months-35.49%
Current year-47.30%
1 week 13.51
Extreme 13.51
15.5
1 month 11.41
Extreme 11.41
18.04
Current year 9.92
Extreme 9.92
35.58
1 year 9.92
Extreme 9.92
35.58
3 years 9.92
Extreme 9.92
84.6
5 years 9.92
Extreme 9.92
180.06
10 years 9.92
Extreme 9.92
306.72
Manager TitleAgeSince
Chief Executive Officer 61 2024-05-05
Director of Finance/CFO 48 2026-07-05
Chief Operating Officer 57 2024-11-14
Director TitleAgeSince
Chairman 72 2022-12-10
Director/Board Member 71 2021-12-31
Director/Board Member 82 1992-12-31
Date Insider Type Main position Quantity % Market Cap.
8/15/26 Fiscal year

EVP Global Port. Mgmt & Mkting

1,054 0.0015%
7/15/26 Free

Chief Financial Officer

356,555 0.5251%
7/6/26 Other

Chief Financial Officer

0 0%
Change 5-day change 1-year change 3-year change Capi.($)
+3.86%+12.06%-45.57%-80.48% 1.03B
-1.16%+3.79%+23.78%-30.93% 17.8B
+15.78%+0.07%-30.47%+110.64% 1.73B
-0.83%-2.98%-25.27%+20.54% 962M
-0.11%+0.22%+62.28%-5.56% 780M
+2.67%+1.05%-38.28%-44.75% 689M
+3.43%-8.53%-44.27%-48.79% 563M
-2.03%-0.28%-40.78%-37.85% 459M
+0.73%+9.13%+75.44%+52.57% 455M
-0.18%+5.61%-6.97%-8.00% 413M
Average +2.18%+4.21%-7.01%-7.26% 2.49B
Weighted average by Cap. +0.50%+6.75%+12.43%-19.39%

Financials

2026 *2027 *
Net sales 2.54B 2.18B 2.04B 1.87B 3.52B 243B 3.56B 24.1B 9.38B 122B 9.55B 9.35B 405B 2.59B 2.22B 2.08B 1.9B 3.59B 247B 3.62B 24.54B 9.56B 125B 9.73B 9.52B 413B
Net income -282M -241M -226M -207M -390M -26.84B -394M -2.67B -1.04B -13.54B -1.06B -1.03B -44.85B -190M -163M -153M -140M -263M -18.14B -266M -1.8B -702M -9.15B -715M -699M -30.31B
Net Debt 2.71B 2.32B 2.18B 1.99B 3.75B 259B 3.79B 25.69B 10B 130B 10.19B 9.96B 432B 2.62B 2.25B 2.11B 1.92B 3.63B 250B 3.67B 24.86B 9.68B 126B 9.85B 9.64B 418B
Logo QuidelOrtho Corporation
QuidelOrtho Corporation provides in vitro diagnostics, developing and manufacturing intelligent solutions. The Company specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. It provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics, Ortho Optix and others.
Employees
6,500
Date Price Change Volume
26-08-25 US$15.05 +3.86% 987,350
26-08-24 US$14.49 -1.70% 1,039,094
26-08-21 US$14.74 -0.74% 2,022,153
26-08-20 US$14.85 +7.61% 2,508,016
26-08-19 US$13.80 +2.76% 1,315,285
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
15.05USD
Average target price
14.67USD
Spread / Average Target
-2.55%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. QDEL Stock